John Galbincea

867 total citations
13 papers, 636 citations indexed

About

John Galbincea is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, John Galbincea has authored 13 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in John Galbincea's work include Acute Myeloid Leukemia Research (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer Genomics and Diagnostics (2 papers). John Galbincea is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer Genomics and Diagnostics (2 papers). John Galbincea collaborates with scholars based in United States, Canada and Venezuela. John Galbincea's co-authors include Rajyalakshmi Luthra, L. Jeffrey Medeiros, Bedia A. Barkoh, Michael A. Davies, Alexander J. Lazar, Keyur P. Patel, Shalini Verma, Zhuang Zuo, Kenneth Aldape and Hui Yao and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

John Galbincea

13 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Galbincea United States	10	361	293	106	94	85	13	636
Diana O. Treaba United States	14	394 1.1×	179 0.6×	147 1.4×	151 1.6×	156 1.8×	51	774
Leo M. Budel Netherlands	13	332 0.9×	201 0.7×	108 1.0×	84 0.9×	242 2.8×	24	780
V. Heilmann Germany	15	342 0.9×	200 0.7×	67 0.6×	186 2.0×	116 1.4×	32	870
Qiuliang Wu China	16	446 1.2×	407 1.4×	115 1.1×	275 2.9×	96 1.1×	37	922
Jeffrey J. Pu United States	14	241 0.7×	214 0.7×	65 0.6×	59 0.6×	81 1.0×	50	686
Salim Yazji United States	12	303 0.8×	220 0.8×	155 1.5×	68 0.7×	186 2.2×	29	738
Pia Klausen Denmark	16	387 1.1×	246 0.8×	118 1.1×	96 1.0×	105 1.2×	33	928
Klaus Fenchel Germany	14	340 0.9×	258 0.9×	164 1.5×	61 0.6×	109 1.3×	31	855
Anna Mozos Spain	15	182 0.5×	292 1.0×	60 0.6×	139 1.5×	196 2.3×	37	795
Annet Simons Netherlands	17	144 0.4×	239 0.8×	145 1.4×	96 1.0×	154 1.8×	29	800

Countries citing papers authored by John Galbincea

Since Specialization

Citations

This map shows the geographic impact of John Galbincea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Galbincea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Galbincea more than expected).

Fields of papers citing papers by John Galbincea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Galbincea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Galbincea. The network helps show where John Galbincea may publish in the future.

Co-authorship network of co-authors of John Galbincea

This figure shows the co-authorship network connecting the top 25 collaborators of John Galbincea. A scholar is included among the top collaborators of John Galbincea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Galbincea. John Galbincea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Patel, Keyur P., Roberto Ruiz‐Cordero, Wei Chen, et al.. (2018). Ultra-Rapid Reporting of GENomic Targets (URGENTseq). Journal of Molecular Diagnostics. 21(1). 89–98. 24 indexed citations

Alayed, Khaled, L. Jeffrey Medeiros, Keyur P. Patel, et al.. (2016). BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Human Pathology. 52. 61–67. 56 indexed citations

Mehrotra, Meenakshi, Rajyalakshmi Luthra, Rajesh R. Singh, et al.. (2015). Clinical Validation of a Multipurpose Assay for Detection and Genotyping ofCALRMutations in Myeloproliferative Neoplasms. American Journal of Clinical Pathology. 144(5). 746–755. 9 indexed citations

Meyer, Larissa A., Brian M. Slomovitz, Bojana Djordjevic, et al.. (2014). The Search Continues. International Journal of Gynecological Cancer. 24(4). 713–717. 17 indexed citations

Paniz‐Mondolfi, Alberto, Rajesh R. Singh, George Jour, et al.. (2014). Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(3). 339–350. 31 indexed citations

Taggart, Melissa W., John Galbincea, Paul F. Mansfield, et al.. (2013). High-level Microsatellite Instability in Appendiceal Carcinomas. The American Journal of Surgical Pathology. 37(8). 1192–1200. 36 indexed citations

Greaves, Wesley O., Shalini Verma, Keyur P. Patel, et al.. (2012). Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma. Journal of Molecular Diagnostics. 15(2). 220–226. 173 indexed citations

Slomovitz, Brian M., John Galbincea, Taren Johnston, et al.. (2011). The search continues: Looking for predictive biomarkers for response mTOR inhibition in endometrial cancer.. Journal of Clinical Oncology. 29(15_suppl). 5016–5016. 8 indexed citations

Galbincea, John, et al.. (2011). A model for rewarding professional growth in the diagnostic molecular oncology laboratory.. PubMed. 37(2). 80–3. 3 indexed citations

10.

Yin, C. Cameron, Jörge E. Cortes, John Galbincea, et al.. (2010). Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays. Cancer Science. 101(9). 2005–2010. 13 indexed citations

11.

Lennon, Patrick A., Srđan Verstovšek, Bedia A. Barkoh, et al.. (2010). Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations. Cancer Genetics and Cytogenetics. 197(1). 1–7. 14 indexed citations

12.

Torres‐Cabala, Carlos A., Wei‐Lien Wang, Jonathan C. Trent, et al.. (2009). Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Modern Pathology. 22(11). 1446–1456. 152 indexed citations

13.

Zuo, Zhuang, Su S. Chen, Pranil Chandra, et al.. (2009). Application of COLD-PCR for improved detection of KRAS mutations in clinical samples. Modern Pathology. 22(8). 1023–1031. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact